Literature DB >> 8797472

Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Sträussler-Scheinker disease (PrP-P102L mutation).

P Barbanti1, G Fabbrini, M Salvatore, R Petraroli, F Cardone, B Maras, M Equestre, G Macchi, G L Lenzi, M Pocchiari.   

Abstract

We present a new, large, Italian family affected by Gerstmann-Sträussler-Scheinker syndrome (GSS) associated with the Pro to Leu point mutation at codon 102 of the prion protein gene (PRNP). The affected members of this family show a remarkable phenotypic variability of the disease: three of them had a clinical picture characterized by dementia and a brief illness duration (less than 1 year), while the other five members presented an ataxic, slowly evolving syndrome (a clinical duration of 3 to 4 years) with no evidence of cognitive impairment. Despite these remarkable clinical differences among affected members, we found no correlation between the clinical presentation and the codon 129 or codon 219 genotypes. These data suggest that factors as yet unidentified may influence the clinical expression of the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797472     DOI: 10.1212/wnl.47.3.734

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

3.  Genomic and post-genomic analyses of human prion diseases.

Authors:  Maurizio Pocchiari; Anna Poleggi; Serena Principe; Silvia Graziano; Franco Cardone
Journal:  Genome Med       Date:  2009-06-22       Impact factor: 11.117

4.  Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan.

Authors:  Nai-Fang Chi; Yi-Chung Lee; Yi-Chun Lu; Hsiu-Mei Wu; Bing-Wen Soong
Journal:  J Neurol       Date:  2009-08-21       Impact factor: 4.849

5.  Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.

Authors:  P Parchi; S G Chen; P Brown; W Zou; S Capellari; H Budka; J Hainfellner; P F Reyes; G T Golden; J J Hauw; D C Gajdusek; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

6.  Atypical frontotemporal dementia as a new clinical phenotype of Gerstmann-Straussler-Scheinker disease with the PrP-P102L mutation. Description of a previously unreported Italian family.

Authors:  Anna Rita Giovagnoli; Giuseppe Di Fede; Anna Aresi; Fabiola Reati; Giacomina Rossi; Fabrizio Tagliavini
Journal:  Neurol Sci       Date:  2008-11-21       Impact factor: 3.307

7.  Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.

Authors:  W S Caughey; L D Raymond; M Horiuchi; B Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease with the P102L mutation.

Authors:  Salvatore Monaco; Michele Fiorini; Alessia Farinazzo; Sergio Ferrari; Matteo Gelati; Pedro Piccardo; Gianluigi Zanusso; Bernardino Ghetti
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution.

Authors:  Yusei Shiga; Katsuya Satoh; Tetsuyuki Kitamoto; Sigenori Kanno; Ichiro Nakashima; Shigeru Sato; Kazuo Fujihara; Hiroshi Takata; Keigo Nobukuni; Shigetoshi Kuroda; Hiroki Takano; Yoshitaka Umeda; Hidehiko Konno; Kunihiko Nagasato; Akira Satoh; Yoshito Matsuda; Mitsuru Hidaka; Hirokatsu Takahashi; Yasuteru Sano; Kang Kim; Takashi Konishi; Katsumi Doh-ura; Takeshi Sato; Kensuke Sasaki; Yoshikazu Nakamura; Masahito Yamada; Hidehiro Mizusawa; Yasuo Itoyama
Journal:  J Neurol       Date:  2007-11-02       Impact factor: 6.682

10.  Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein.

Authors:  Emmanuel A Asante; Jacqueline M Linehan; Michelle Smidak; Andrew Tomlinson; Andrew Grimshaw; Asif Jeelani; Tatiana Jakubcova; Shyma Hamdan; Caroline Powell; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.